Yosuke Aoyama

5PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyModels of care and place of birthCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 02, 2026
Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.

|Mar 30, 2026
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial.

Yosuke Aoyama, Kosuke Kashiwabara, Yuichiro Kikawa

|Dec 05, 2025
Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy.

Meiko Nishimura, Takayuki Kobayashi, Yosuke Aoyama

|Dec 07, 2024
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.

Yosuke Aoyama, Yukinori Ozaki, Rika Kizawa

|Dec 11, 2023
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale.

Yosuke Aoyama, Eri Hoshino, Akihiko Shimomura

Pageof 1

Frequent Collaborators

3 joint publications

Meiko Nishimura

3 joint publications

Takayuki Ueno

3 joint publications

Nami Yamashita

3 joint publications

Toshimi Takano